11/14/2024 9:00 AM | Compass Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
09/08/2024 11:15 PM | Compass Therapeutics (Filer)
| Form EFFECT | |
08/30/2024 4:23 PM | Compass Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/14/2024 7:49 AM | Anderman Jonathan (Reporting) Compass Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 7:00 AM | Compass Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2024 7:00 AM | Compass Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/17/2024 7:32 AM | Compass Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
05/28/2024 3:09 PM | Compass Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 7:00 AM | Compass Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 7:01 AM | Compass Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 7:00 AM | Compass Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024 7:01 AM | Compass Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024 7:02 AM | Compass Therapeutics (Filer)
| Form ARS | |
04/25/2024 7:00 AM | Compass Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 3:59 PM | Compass Therapeutics (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
03/21/2024 8:00 AM | Compass Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2024 8:00 AM | Compass Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/11/2024 9:12 AM | Boylan James P (Reporting) Compass Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 11:03 AM | Compass Therapeutics (Issuer) LINDAHL RICHARD S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 11:03 AM | Compass Therapeutics (Issuer) GRAY MARY ANN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 11:00 AM | Compass Therapeutics (Issuer) Ferneau Philip (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 11:01 AM | Chiniara Ellen (Reporting) Compass Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 11:02 AM | Compass Therapeutics (Issuer) GORDON CARL L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 11:50 AM | Bisker-Leib Vered (Reporting) Compass Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 11:49 AM | Compass Therapeutics (Issuer) Schuetz Thomas J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:50 AM | Compass Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024 6:05 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Compass Therapeutics (Subject)
| Form SC 13G/A | |
02/01/2024 9:19 AM | Compass Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
01/10/2024 9:31 AM | Compass Therapeutics (Issuer) Schuetz Thomas J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 9:31 AM | Bisker-Leib Vered (Reporting) Compass Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 4:30 PM | Compass Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 7:00 AM | Compass Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2023 1:08 PM | Compass Therapeutics (Issuer) Schuetz Thomas J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 1:10 PM | Bisker-Leib Vered (Reporting) Compass Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |